Goldman Sachs’s CAS Medical Systems, Inc. CASM Stock Holding History

Goldman Sachs’s Portfolio CASM Stock Details CASM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-83,378	Closed	-$203K	–	5523
2019 Q1	$203K	Buy	+83,378	New	+$179K	﹤0.01%	4794
2015 Q4	–	Sell	-11,365	Closed	-$14K	–	7495
2015 Q3	$14K	Sell	11,365 -2,422	-18%	-$2.87K	﹤0.01%	7103
2015 Q2	$18K	Buy	+13,787	New	+$17.9K	﹤0.01%	7094

Goldman Sachs's CASM Position: Q2 2019 in Review

Goldman Sachs sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 83,378 shares — an estimated $203K sold.

Goldman Sachs first reported a position in CASM in Q2 2015 and held it in 3 quarters. The position peaked at $203K in Q1 2019. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.

Goldman Sachs reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
Goldman Sachs sold 83,378 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $203K.
Goldman Sachs first reported a position in CAS Medical Systems, Inc. in Q2 2015 and held it in 3 quarters.
Goldman Sachs's CAS Medical Systems, Inc. position peaked at $203K in Q1 2019.
0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.

Based on Goldman Sachs's 13F filing for Q2 2019, filed 14 Aug 2019.